Response to Letter to the Editor regarding “Comparing Long-Term survival benefits of hepatocellular carcinoma between thermal ablation monotherapy and combined therapy with transarterial Chemoembolization: A propensity score matched study”-Reference-Cited by-同舟云学术

Response to Letter to the Editor regarding “Comparing Long-Term survival benefits of hepatocellular carcinoma between thermal ablation monotherapy and combined therapy with transarterial Chemoembolization: A propensity score matched study”

Published:2023-12 Issue: Volume:169 Page:111193
ISSN:0720-048X
Container-title:European Journal of Radiology
language:en
Short-container-title:European Journal of Radiology

Author:

Zhang Ke,Mu Lei,Ren Yiyue,Jiang Tianan^ORCID

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference7 articles.

1. Comparing Long-Term survival benefits of hepatocellular carcinoma between thermal ablation monotherapy and combined therapy with transarterial Chemoembolization: A propensity score matched study;Zhang;Eur. J. Radiol.,2023

2. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study

3. Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma;Hirooka;AJR Am. J. Roentgenol.,2018

4. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma;Yin;BMC Cancer,2014

5. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma;Song;Korean J. Intern. Med.,2016